melatonin has been researched along with Leiomyoma in 2 studies
Leiomyoma: A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels." | 7.69 | Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997) |
| "Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells." | 5.56 | Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. ( Chen, HY; Chiang, YF; Hong, HC; Hsia, SM; Hsu, SP; Huang, KC; Huang, TC; Lin, PH; Tung, YT, 2020) |
| "In previous studies a tumor-size dependent decline of the circadian amplitude of serum melatonin was found in primary unoperated breast cancer patients, which was not due to changes of the hepatic metabolism of melatonin since its main peripheral metabolite, 6-sulphatoxymelatonin (aMT6s), showed similar serum levels." | 3.69 | Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size. ( Bartsch, C; Bartsch, H; Franz, H; Karenovics, A; Mecke, D; Peiker, G, 1997) |
| "Treatment with melatonin increased the distribution of sub-G1 phase and increased DNA condensation in ELT3 cells." | 1.56 | Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation. ( Chen, HY; Chiang, YF; Hong, HC; Hsia, SM; Hsu, SP; Huang, KC; Huang, TC; Lin, PH; Tung, YT, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, PH | 1 |
| Tung, YT | 1 |
| Chen, HY | 1 |
| Chiang, YF | 1 |
| Hong, HC | 1 |
| Huang, KC | 1 |
| Hsu, SP | 1 |
| Huang, TC | 1 |
| Hsia, SM | 1 |
| Bartsch, C | 1 |
| Bartsch, H | 1 |
| Karenovics, A | 1 |
| Franz, H | 1 |
| Peiker, G | 1 |
| Mecke, D | 1 |
2 other studies available for melatonin and Leiomyoma
| Article | Year |
|---|---|
Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Line, Tumor; Cell Proliferation; Female; Humans; Leio | 2020 |
Nocturnal urinary 6-sulphatoxymelatonin excretion is decreased in primary breast cancer patients compared to age-matched controls and shows negative correlation with tumor-size.
Topics: Breast Neoplasms; Female; Fibroadenoma; Fibrocystic Breast Disease; Humans; Leiomyoma; Melatonin; Mi | 1997 |